Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 31% ± 13% | |
kidney | 11 studies | 42% ± 20% | |
heart | 7 studies | 39% ± 9% | |
intestine | 5 studies | 35% ± 15% | |
uterus | 5 studies | 58% ± 14% | |
adipose | 5 studies | 28% ± 8% | |
pancreas | 4 studies | 48% ± 6% | |
brain | 4 studies | 28% ± 9% | |
breast | 4 studies | 33% ± 6% | |
peripheral blood | 3 studies | 28% ± 11% | |
esophagus | 3 studies | 18% ± 2% | |
prostate | 3 studies | 27% ± 8% | |
skin | 3 studies | 37% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 56741.39 | 89 / 89 | 100% | 1223.99 | 901 / 901 |
breast | 99% | 28262.57 | 454 / 459 | 96% | 370.37 | 1078 / 1118 |
prostate | 98% | 25483.82 | 239 / 245 | 98% | 355.88 | 490 / 502 |
thymus | 100% | 51507.54 | 652 / 653 | 95% | 470.53 | 574 / 605 |
adrenal gland | 98% | 17131.51 | 252 / 258 | 95% | 465.68 | 218 / 230 |
lung | 99% | 25298.92 | 572 / 578 | 90% | 293.67 | 1044 / 1155 |
ovary | 89% | 16152.02 | 160 / 180 | 98% | 402.35 | 420 / 430 |
bladder | 95% | 26011.43 | 20 / 21 | 87% | 303.62 | 436 / 504 |
uterus | 99% | 26830.84 | 169 / 170 | 78% | 226.80 | 358 / 459 |
intestine | 83% | 16833.39 | 801 / 966 | 92% | 381.03 | 486 / 527 |
esophagus | 69% | 16283.52 | 997 / 1445 | 86% | 253.07 | 158 / 183 |
pancreas | 48% | 5239.19 | 157 / 328 | 98% | 894.03 | 175 / 178 |
stomach | 47% | 8920.55 | 167 / 359 | 95% | 417.69 | 273 / 286 |
skin | 57% | 7231.57 | 1039 / 1809 | 82% | 319.02 | 386 / 472 |
brain | 25% | 2310.36 | 654 / 2642 | 97% | 491.04 | 686 / 705 |
liver | 42% | 4788.92 | 94 / 226 | 75% | 221.51 | 306 / 406 |
blood vessel | 100% | 157384.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 117.19 | 1 / 1 |
adipose | 100% | 38558.34 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 28902.64 | 848 / 861 | 0% | 0 | 0 / 0 |
spleen | 96% | 20687.51 | 231 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 166.21 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 154.59 | 37 / 45 |
eye | 0% | 0 | 0 / 0 | 81% | 310.65 | 65 / 80 |
muscle | 24% | 2321.63 | 195 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032526 | Biological process | response to retinoic acid |
GO_0009966 | Biological process | regulation of signal transduction |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0007155 | Biological process | cell adhesion |
GO_0001558 | Biological process | regulation of cell growth |
GO_0051414 | Biological process | response to cortisol |
GO_0050810 | Biological process | regulation of steroid biosynthetic process |
GO_0007566 | Biological process | embryo implantation |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005520 | Molecular function | insulin-like growth factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | IGFBP7 |
Protein name | Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (IGFBP-rP1) (MAC25 protein) (PGI2-stimulating factor) (Prostacyclin-stimulating factor) (Tumor-derived adhesion factor) (TAF) |
Synonyms | PSF MAC25 |
Description | FUNCTION: Binds IGF-I and IGF-II with a relatively low affinity. Stimulates prostacyclin (PGI2) production. Stimulates cell adhesion. . |
Accessions | ENST00000295666.6 [Q16270-1] Q16270 ENST00000514062.2 [Q16270-2] |